Literature DB >> 12454684

Oral therapy for Peyronie's disease.

L A Mynderse1, M Monga.   

Abstract

Peyronie's disease (PD) remains a therapeutic dilemma for the urologist. Despite a myriad of medical therapies proposed for PD there have been limited advances in oral medical treatment. Several new approaches are presented which hold promise of success, although a definitive medical therapy for PD has yet to be established. Since early stage disease is reputed to respond better than well-established plaques, an early trial of inexpensive, safe and well-tolerated oral therapy is often initially recommended. This review discusses the historical aspects as well as contemporary oral medical therapy for PD. With advances in the molecular biology of inflammation and wound healing, the management and understanding of this frustrating disease will no doubt improve.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454684     DOI: 10.1038/sj.ijir.3900869

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  3 in total

1.  [Assessment among German urologists of various conservative treatment modalities for Peyronie's disease. Results of a survey].

Authors:  E W Hauck; T Bschleipfer; S M Haag; V Rohde; W Weidner
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

Review 2.  Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.

Authors:  Elizabeth J Traore; William Wang; Faysal A Yafi; Wayne J G Hellstrom
Journal:  Ther Adv Urol       Date:  2016-03-22

3.  Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.

Authors:  Abas Kokab; Kevan Wylie; Patricia Allen; Abhijeeth Shetty; Debbie Davies-South
Journal:  Adv Urol       Date:  2014-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.